BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 12, 2019
View Archived Issues
Murine model reveals TRPA1 loss is involved in age-related dilated cardiomyopathy
Read More
Molecular Partners initiates first-in-human study of MP-0310
Read More
Tiziana presents phase I results for nasal foralumab
Read More
Positive CTC data from phase II TYME-88-PANC study of SM-88
Read More
ANKRD12 as a novel biomarker in schizophrenia and bipolar disorder
Read More
S100-B found to be a peripheral biomarker for estimating addiction treatment efficacy
Read More
NEK7 identified as potential biomarker associated with obsessive compulsive disorder
Read More
Transgenic CYP2C19 mouse as a new animal model for hyperdopaminergism-induced hyperkinesia
Read More
Gilead discloses new HIV replication inhibitors
Read More
Incyte presents new MAP4K1 inhibitors
Read More
New analgesics synthesized at Daiichi Sankyo
Read More
Memorial Sloan-Kettering Cancer Center patents anticancer agents
Read More
Girafpharma describes cyclin-dependent kinase inhibitors
Read More
KAHR Medical, Roche trial collaboration to test DSP-107/atezolizumab in lung cancer
Read More
Phio Pharmaceuticals enters agreement with Carisma Therapeutics to enhance adoptive cell therapy
Read More
P53 upregulation predicts malaria immunity in children
Read More
FDA approves Xeris' Gvoke, first ready-to-use stable liquid glucagon for severe hypoglycemia
Read More
Oryzon Genomics presents preliminary phase II data on iadademstat in SCLC
Read More
Glioblastoma stem cells co-opt circadian pacemakers
Read More
Ocrelizumab in RRMS: CASTING study phase III results presented
Read More
Tubulis enters collaboration with Glycotope for development of novel ADC therapy
Read More
Adverum reports 24-week cohort 1 data from phase I study of ADVM-022 in wet AMD
Read More
Prevail Therapeutics advances development of PR-001 for Parkinson's and Gaucher's diseases
Read More
Moderna offers phase I data from chikungunya and CMV programs
Read More